NCT00667004已完成2 期
Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 183
- 试验地点
- 1
- 主要终点
- Mean Change From Baseline in Lacrimation Assessed by Schirmer's Test
研究概览
简要总结
Efficacy study of ecabet ophthalmic solution in dry eye disease
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed with dry eye disease
排除标准
- •Dry eye disease secondary to surgery
研究组 & 干预措施
1
Experimental
ecabet ophthalmic solution
干预措施: ecabet ophthalmic solution (Drug)
2
Placebo Comparator
Placebo comparator
干预措施: placebo (Drug)
结局指标
主要结局
Mean Change From Baseline in Lacrimation Assessed by Schirmer's Test
时间窗: 43 days
The Schirmer's test is used determine if tear glands produce enough tears to keep eyes adequately moist. Calibrated strips of a non-toxic filter paper are used. One free end is placed within the lower eyelid. At the conclusion of the test, the paper strip is removed from the lower eyelid and the amount of wetting of the paper strip is measured.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye SyndromeDry Eye SyndromesNCT00198536Bausch & Lomb Incorporated159
已完成
2 期
Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye SyndromeDry Eye SyndromesNCT00370747Bausch & Lomb Incorporated162
已完成
不适用
Cross-linked CMC and Silk Proteins in Eye DiseaseDry Eye Disease (DED)NCT06605365D&V FARMA srl20
已完成
2 期
Safety and Efficacy of an Ophthalmic Solution in Dry Eye DiseaseDry Eye DiseaseNCT00758784Bausch & Lomb Incorporated38
已完成
不适用
Cross-linked Hyaluronic Acid and Coenzyme Q10 in the Treatment of Dry EyeDry Eye SyndromeNCT03074344Azienda Ospedaliera Universitaria Policlinico "G. Martino"40